215 results about "Insulin injection" patented technology

The invention relates to the technical field of artificial intelligence, and discloses a blood glucose management system based on artificial intelligence. According to the system, blood glucose monitoring is reminded through the blood glucose monitoring terminal, a blood glucose curve is drawn every week, abnormal blood glucose conditions are judged for reminding and alarming, the diet terminal is used for guiding low-sugar diet recommendation, high-sugar food intake is avoided, the mastering degree of a patient and family members for food classification is improved, and the exercise terminal determines the exercise time and exercise amount of the patient according to the blood glucose value. Parameters are input into an intelligent system, the system converts and selects a motion mode, time and intensity, a drug treatment terminal calculates the insulin injection amount of a patient every day and every meal according to the blood glucose level and food intake, the insulin dosage is adjusted according to the calculated numerical values, blood glucose fluctuation is reduced, and the treatment effect is improved. The education and self-management terminal guides a patient to improve the cognitive degree of diabetes and provides personalized propaganda and education guidance for the patient, and the complication reminding terminal controls the blood sugar of the patient within a normal range, guides a good lifestyle of the patient and guides behavior specifications.

An automated insulin delivery system provides an insulin injection that is computed by adding (i) the recommendation of an artificial neural network trained to mimic a constrained model predictive controller dosing rule from a neural network implementing an artificial pancreas (ii) a hypoglycemia mitigation system includeds a correction (one dose computed as the correction down to 110mg / dl based on prevailing continuous glucose monitoring and once an hour at most, unless there is a triggering BPS and G>180 mg / dl), and (iii) the current basal rate (output of the Performance Assessment System, (PAS)); that amount is then saturated by the Safety Supervision System, SSM. Finally, a priming bolus from the Bolus Priming System, BPS, is added to the total if the conditions for large glycemic excursions are detected, also saturated by SSM.

The invention discloses a chronic disease tracking management system, and belongs to the technical field of chronic disease patient management, and the system comprises a primary medical worker training module which is used for carrying out the skill and knowledge training of primary medical workers; the patient baseline data collection module is used for collecting patient baseline data and performing data analysis; the patient tracking guidance module is used for providing main control index monitoring guidance, daily nursing guidance, prevention control guidance, insulin injection guidance and the like for the patient; the prevention and improvement action plan module is used for monitoring health indexes of the patient, and regularly evaluating and timely adjusting a treatment scheme; analyzing and providing improvement suggestions according to the living habits of the patient; and the medical nutrition treatment module is used for formulating a personalized diet scheme with balanced nutrition for the patient. The system is intelligent, personalized and comprehensive, the chronic disease management level is integrally improved, and chronic disease prevention and treatment work is facilitated.

A diabetes management system adapted to determine adherence for a subject in treatment according to a basal insulin regimen, the system being adapted to receive regimen data. BG data and insulin injection data. If one or more insulin injections have not been received in accordance with the prescribed regimen and thus are missing, the system is adapted to calculate for each missing injection an expected dose response BG value. By comparing received BG data, corresponding to the missing insulin injections, it can be determined for a given confidence interval whether or not the subject has been in adherence with the basal insulin regimen.

The present invention provides an insulin injection pen, belonging to the technical field of medical devices, which includes an injection pen body and a needle head seat. The needle head seat includes a base, a syringe barrel, a rotating disk, an upper cover, a driving mechanism and a replacement mechanism. A linkage column is disposed downward at the bottom of the syringe barrel. The replacement mechanism forms a replacement position on the rotation path of the syringe barrel. The replacement mechanism includes an upper clamping assembly and a lower clamping assembly disposed at the replacement position. In the present invention, by rotating the rotating disk, any syringe barrel can be stopped at the replacement position, then the pen body is aligned with the needle head in the syringe barrel, and then the second gear is driven to rotate by the driving mechanism, driving the syringe barrel to rotate and driving the needle head to rotate. At the same time, the driving mechanism enables the needle head to be automatically connected or disassembled from the pen body, improving the safety of user use. Moreover, the used needle head can be temporarily stored in the syringe barrel for unified treatment, avoiding environmental pollution caused by random discard.

A mathematical model of type 1 diabetes (T1D) patient decision-making can be used to simulate, in silico, realistic glucose / insulin dynamics, for several days, in a variety of subjects who take therapeutic actions (e.g. insulin dosing) driven by either self-monitoring blood glucose (SMBG) or continuous glucose monitoring (CGM). The decision-making (DM) model can simulate real-life situations and everyday patient behaviors. Accurate submodels of SMBG and CGM measurement errors are incorporated in the comprehensive DM model. The DM model accounts for common errors the patients are used to doing in their diabetes management, such as miscalculations of meal carbohydrate content, early / delayed insulin administrations and missed insulin boluses. The DM model can be used to assess in silico if / when CGM can safely substitute SMBG in T1D management, to develop and test guidelines for CGM driven insulin dosing, to optimize and individualize off-line insulin therapies and to develop and test decision support systems.

The invention discloses an insulin injection pen, and belongs to the technical field of medical instruments. Comprising a main body shell, a connecting sleeve and a medicine bin, and the main body shell is connected with the medicine bin through the connecting sleeve; the adjusting mechanism comprises a dosage rotating cylinder and a transmission pipe, the dosage rotating cylinder is arranged in the main body shell and is in threaded connection with the main body shell, and the transmission pipe is arranged in the dosage rotating cylinder and is in clutch connection with the dosage rotating cylinder; the driving mechanism is arranged in the transmission pipe, and the driving mechanism is matched with the connecting sleeve to form an injection sound production structure; the insulin injection pen is switched from a dose adjusting state to an injection state through up-down separation and reunion of the transmission tube, and the insulin injection pen is injected and dosed through the driving mechanism. The connecting sleeve is made of a plastic part with high hardness, even if the medicament bottle gives reactive force to the driving mechanism during injection, the matching precision between the driving mechanism and the connecting sleeve is not affected, the reliability of the injection sound production structure is improved, and the problem of deformation or failure possibly occurring after the reactive force during long-term injection administration is avoided.

The utility model discloses a multifunctional insulin injection device which comprises an insulin injection pen, a needle tube is fixedly arranged at the lower end of the insulin injection pen, an injection needle is fixedly arranged at the lower end of the needle tube, and a pen cover is movably arranged at the lower end of the insulin injection pen in a clamped mode. A disinfection mechanism used for disinfecting an injection area is arranged at the lower end of the pen cap and comprises a fixing ring, a protective shell, a rubber sleeve and a cotton brush head, the fixing ring is fixedly arranged at the lower end of the pen cap, the protective shell is arranged on the outer side surface of the fixing ring, and the rubber sleeve is fixedly arranged at the position, inside the fixing ring, of the lower end of the pen cap. A cotton brush head is fixedly arranged at the lower end of the rubber sleeve. The insulin injection pen is good in using effect and complete in functionality, the disinfection function is additionally added, an injection area can be disinfected before injection, then injection is conducted, the disinfection function and the insulin injection pen are integrated, and the insulin injection pen is convenient to carry and use and complete in functionality.

The utility model relates to an auxiliary fixing device for injection, which comprises a fixing frame, two sides of the fixing frame are respectively provided with a binding belt, one end of one binding belt is provided with a locking buckle matched with the other binding belt, and the other end of the other binding belt is provided with a locking buckle matched with the other binding belt. Two corresponding kneading rollers are installed on the side, close to the abdomen, of the interior of the fixing frame, in the using process, after a part needing injection is confirmed, the abdomen can be squeezed under the action of the two kneading rollers, and the skin in the corresponding area is made to protrude towards the rubber cover; meanwhile, under the action of a plurality of elastic mechanisms, the rubber cover is tightly attached to the upheaval part of the abdomen, then a user inserts an insulin injection pen into the upheaval part from the interior of a limiting barrel, in this way, insulin can be correctly injected into the body of a patient, and the situation that the patient is pricked askew during injection is reduced; and a patient can accurately pierce into a part needing to be injected, so that more convenience is brought to people.

An insulin needle extractor is characterized in that a sleeve-shaped shell is designed, the inner cavity of the sleeve is used as a channel, a claw sleeve composed of at least two elastic claws is designed for the channel, a slope or a taper is arranged between the inner wall of the channel of the shell and the outer side of the claw sleeve, the claw sleeve is inserted into the channel of the shell, and the elastic claws are forced to present two working states of opening and contraction relative to the center of the channel during the sliding of the claw sleeve before and after the channel. When the needle is removed, the insulin needle is inserted from the needle removal port in the open state of the elastic claws, and the claw sleeve is moved to the other end in the channel, the elastic claws are forced to contract to the center during the movement due to the effect of the slope or the taper, and the insulin needle is clamped, at this time, the needle extractor can be rotated in the reverse direction until it is separated, and the insulin needle can be removed from the head of the insulin injection pen. The present scheme only has the cooperation of the shell and the needle extraction sleeve (the claw sleeve), has few parts, simple structure, and reliable work.

The invention relates to the technical field of intelligent diabetes treatment instruments, in particular to a closed-loop non-invasive insulin detection and precise infusion system which is characterized by comprising a blood glucose monitoring regulator, a non-invasive injector and a closed-loop control mechanism. The closed-loop control mechanism comprises a real-time blood glucose detection module, a temperature detection module, a blood glucose data processing module, a dose decision module, an injection pressure adjusting module, an injection channel control module, an insulin injection module and a closed-loop feedback module; noninvasive and high-sensitivity real-time blood glucose monitoring is achieved, the accuracy and timeliness of insulin administration are improved through trend prediction and individualized dose decision, meanwhile, multi-nozzle array piezoelectric needleless injection is combined with temperature compensation pressure regulation and a closed loop feedback correction mechanism, local tissue burden is effectively reduced, and the insulin administration efficiency is improved. And through multiple safety protection and wireless data transmission, remote monitoring and intelligent management are realized, so that the convenience, accuracy and reliability of blood glucose management of diabetic patients are greatly improved.

The utility model relates to the technical field of insulin injection, in particular to a disposable sterile insulin syringe. The disposable sterile insulin syringe comprises a syringe barrel, a connecting pipe, a needle head, a stress plate, a piston, a push rod and a push plate, the left end of the syringe barrel is connected with the connecting pipe, the connecting pipe is connected with the needle head, the right end of the syringe barrel is connected with the stress plate, the push rod is connected into the syringe barrel in a sliding mode, and the piston is connected with the push rod. The left end of the push rod is connected with a piston, the right end of the push rod is connected with a push plate, a groove is formed in the lower side of the right end of the push rod, the connecting block is placed in the groove, and the left side of the lower portion of the stress plate is connected with the limiting block and the elastic piece. Through the arrangement of the connecting block, the limiting block and the elastic piece, the push rod can be braked through simple operation, it is ensured that the push rod is not prone to being pulled after an injector is used, medical workers are prompted that the injector is used, and the risk of repeated use is reduced.

The images related to this design are used, for example, to monitor, display, or track measurement data such as blood glucose levels, as well as exercise, insulin administration, and food intake. These images can be operated by tapping, pressing, swiping, or scrolling the display screen, or via other devices associated with the display device.

The injection pump comprises an insulin pump body and further comprises a medicine storage device, a medicine changing assembly, an exhaust device and a medicine pushing assembly, the medicine storage device is detachably connected with the insulin pump body, a plurality of medicine bags are placed in the medicine storage device, the medicine changing assembly is arranged in the medicine storage device, the medicine changing assembly is pressed, and the medicine pushing assembly is arranged in the medicine storage device. The medicine changing assembly automatically changes the medicine bag, the exhaust device is arranged in the insulin pump body and automatically exhausts air after the medicine bag is replaced, the medicine pushing assembly is arranged in the insulin pump body and pushes the medicine bag, and insulin injection in the medicine bag is completed. The device has the advantages that the medicine storage device is used for storing multiple tubes of insulin, the storage amount of the insulin is increased, the medicine changing assembly is used for achieving automatic medicine changing, the medicine changing process is simplified, the medicine changing time is shortened, the exhaust device is used for achieving automatic exhaust of the insulin after changing, the situation that an indwelling needle needs to be pulled out in the insulin changing process is avoided, and repeated needle inserting is avoided; and the comfort of the patient is improved.

The invention discloses an insulin injection data management system, which relates to the technical field of medical health information and comprises a data acquisition module for acquiring injection operation data and blood sugar data from an insulin injection pen and lifestyle data input by a user; the intelligent analysis module is used for generating insulin dose recommendation information through a predefined dose calculation model on the basis of the injection operation data, the blood glucose data and the life style data, and generating injection site rotation recommendation information on the basis of injection site information in the injection operation data; the early warning prompt module is used for generating and outputting a dose early warning and a failure early warning based on dose information and temperature information in the injection operation data; and the medical care collaboration module is used for providing a data access interface for authorized medical care personnel and adjusting parameters of the dose calculation model based on remote instructions of the medical care personnel. And accurate and dynamic recommendation of dosage, scientific alternating guidance of injection parts and active early warning of dosage and failure are realized.

An insulin delivery device includes an insulin injection device in communication with a controller for controlling the insulin injection device. The controller is configured to receive a heart signal from one or more heart sensors, and a blood glucose signal from one or more blood glucose sensors. The controller is further configured to analyze changes in the heart rhythm of the subject based on the heart signal and determine, based on the changes in the heart rhythm and the blood glucose signal, whether the subject is and / or will be experiencing an adverse event. Upon determination that the subject is or will be experiencing an adverse event, the controller determines one or more parameters of delivery of insulin to be delivered to the subject. Finally, the controller is configured to control the injection device to deliver insulin to the subject in accordance with the determined one or more parameters of delivery.

A kind of pen core screw rod pump for insulin injection, shell, pen core injection mechanism, primary screw rod telescopic mechanism, secondary screw rod telescopic mechanism, power device, power module and intelligent control module, power device is connected with primary screw rod telescopic mechanism transmission, secondary screw rod telescopic mechanism is installed in primary screw rod telescopic mechanism and is connected with primary screw rod telescopic mechanism transmission, pen core injection mechanism is set in the upper portion of secondary screw rod telescopic mechanism, key operation module is equipped on the shell, sensor assembly is set on primary screw rod telescopic mechanism, power module provides power to power device and intelligent control module respectively, and intelligent control module is connected with power device, key operation module and sensor assembly signal respectively.This application can accurately control the injection amount of insulin liquid, realize high-precision drug delivery, significantly reduce the overall size, the rotation torque and speed of intelligent control power motor, reduce the impact degree, reduce the energy consumption of electric energy, also have anti-lock function.

The invention discloses an insulin sterile injection device for diabetics in the field of insulin injection, which comprises two mounting frames, side brackets are arranged at the upper parts of the sides close to each other, and a middle bracket is arranged between the two side brackets; the left end and the right end of the middle support are connected with the corresponding side supports through height adjusting assemblies respectively, a moving seat capable of moving transversely is arranged on the middle support, an injection positioning mechanism capable of swinging front and back is arranged on the moving seat, and an injector is installed on the injection positioning mechanism. A plurality of transverse connecting belts are connected to the outer sides of the two mounting frames, the outward end of each connecting belt on the left side is fixed to the first fixing part, and the outward end of each connecting belt on the right side is fixed to the second fixing part. The sterile insulin injection device can achieve sterile insulin injection, and injection part infection caused by nonstandard operation is avoided.

The utility model relates to the technical field of insulin injection pens, and discloses an insulin injection pen capable of preventing a needle from being punctured, which comprises an injection pen body and a pen cap, the injection pen body is in threaded connection with a needle seat, the needle seat is fixedly connected with a connecting block, the connecting block is rotatably connected with a first protective shell, and the first protective shell is fixedly connected with the pen cap. According to the insulin injection pen capable of preventing the needle from being punctured, when the insulin injection pen capable of preventing the needle from being punctured is used, injection is conducted or the needle is replaced, the first protective shell and the second protective shell can be opened and closed through the action of pulling the pull ring and the spring, and therefore the insulin injection pen can be used for preventing the needle from being punctured. The needle head is effectively covered and prevented from being exposed, the puncture risk caused by accidental contact of medical staff, patients or other people is greatly reduced, the needle head is replaced by screwing the needle base, the replacement process is simple and rapid, meanwhile, the sealing performance of the needle head is kept, and sanitation and safety of injection are guaranteed.

This application discloses an insulin pen packaging box, relating to the field of pharmaceutical packaging technology. Its key technical features are: an outer box body composed of a box body and a freely opening and closing lid; a paper tray embedded inside the box body, the projection of the paper tray on the horizontal plane coinciding with the bottom of the box body; the paper tray includes a pad, on which multiple insulin pen placement frames are arranged side-by-side, and each placement frame is fixedly connected to the pad; each end of a placement frame has a slot along its length, and when an insulin pen is placed in a slot, the slot provides support and restraint to the end of the insulin pen. This allows for the simultaneous storage of multiple insulin pens within a single packaging box, thus improving packaging efficiency and patient convenience.

The utility model relates to the field of medical auxiliary devices, in particular to an insulin injection site alternation prompting device, which is characterized in that four graphic sheets of a graphic sheet assembly on which four different regional patterns of a human body are drawn are fixedly connected to four side surfaces of a box body, and respective insulin injection permitting sites are drawn in the regions drawn by the four graphic sheets; setting a plurality of injection point positions with unique identification character codes in respective injection parts; the plurality of lamp beads are respectively arranged on the plurality of injection point positions; a plurality of injection positioning holes with identification character codes are respectively formed in four groups of positioning cards of the positioning clamping piece, the plurality of injection positioning holes are in one-to-one correspondence with a plurality of injection point positions of the graphic sheet combined piece, and the identification character codes of the plurality of injection positioning holes are the same as the identification character codes of the respective corresponding injection point positions; by means of automatic prompting of the device, a patient can be helped to timely master injection time and injection positions and injection points needing to be changed each time, and risks affecting the treatment effect can be reduced.

A universal sealing device for an insulin injection bottle opening comprises a fastening mechanism arranged at the bottom and further comprises a hinge and a sealing assembly, and the top of one end of the fastening mechanism is provided with the sealing assembly through the hinge; the sealing assembly comprises a sealing disc, a rubber plug, a second groove, barb columns, a second elastic buckle, a clamping groove, a triangular block and a second inclined face, the sealing disc is connected with the sealing assembly through a hinge, the rubber plug is arranged in the middle of the bottom end of the sealing disc, the second groove is formed in the middle of the rubber plug, and the barb columns are installed in the second groove. A second elastic buckle is fixed to the edge of one end of the sealing disc, a clamping groove is formed in the inner side of the bottom of the second elastic buckle, and a triangular block with the horizontal bottom is fixed to the position, corresponding to the second elastic buckle, of the top end of one side of the second hoop ring. Sealing performance is good, and use is facilitated.

The utility model provides a medicine storage device structure of an insulin pump for the endocrinology department, which belongs to the technical field of medical instruments and comprises a medicine storage device main body, a first milliliter scale is engraved in the center of the outer side surface of the medicine storage device main body; insulin is stored through the medicine storage device main body, the insulin operation required by quantitative extraction before insulin injection is not needed, and the positioning bolt is screwed into the corresponding bolt hole, so that the positioning bolt is attached to the bottom surface of the cross rod, the push rod and the piston are prevented from moving upwards, and the insulin is prevented from being discharged from the liquid discharge connector due to misoperation. When insulin is injected, the positioning bolt is loosened, the upward moving distance of the piston is determined according to the first milliliter scale and the second milliliter scale, then the positioning bolt is screwed into the corresponding bolt hole, the ascending distance of the push rod and the piston is limited, and the effect that the insulin in the medicine storage device body is quantitatively injected into an insulin pump is achieved. And the situation that too much insulin is added due to misoperation of medical staff is prevented.

The utility model discloses a portable insulin preservation cup which is characterized in that an inner ring is fixedly installed in a cup body, a biological ice bag is arranged between the inner ring and the cup body, a fixing seat is fixedly arranged on the inner wall of the inner ring, and the side, away from the inner ring, of the fixing seat is used for storing insulin; the pressing rod is slidably inserted into the fixing base, telescopic blocks are arranged on the two sides of the pressing rod, and a fixing plate is fixedly installed on the surfaces of the telescopic blocks. The support rod is inserted into one side, far away from the inner ring, of the fixed seat; the fixing plate and the supporting rod are arranged in the cup body, after insulin is placed in the cup body, the insulin is fixed through the fixing plate and the supporting rod, insulin damage caused by shaking in the carrying process is avoided, the biological ice bag is placed between the cup body and the inner ring, a low-temperature storage space is formed in the cup body, and the insulin is stored in the low-temperature storage space. Meanwhile, the insulin injection device is convenient to carry when a patient goes out, and the problem that the insulin cannot be injected in time when the patient goes out is solved.

Describes devices, systems, and techniques for controlling the delivery of diabetes therapies. In one example, the system includes: a wearable device configured to generate user activity data associated with a user's arm; and one or more processors configured to: identify, based on the user activity data, at least one gesture indicative of preparing an insulin injection using an injection device; generate, based on the at least one identified gesture, information indicative of at least one of an amount or type of an insulin dose in the insulin injection performed by the injection device; compare the generated information with a standard for an appropriate insulin injection; and, based on the comparison, output information indicative of whether the standard is met.

1. The name of the design product: insulin injection simulation artificial skin. 2. The use of the design product: the product is mainly used to demonstrate injection site selection and injection process in subcutaneous injection education process. 3. The design points of the design product: the combination of shape, pattern and color. 4. The picture or photo that best indicates the design points: perspective view. 5. The design for which protection is sought contains color. 6. The back of the design product is a part that is not easy to see or cannot be seen during use, and the rear view is omitted.

The utility model discloses a novel portable insulin injection pen cold storage device, which relates to the technical field of medical instruments, and comprises a heat preservation cylinder, a plurality of storage cylinders, a plurality of storage cylinders, a plurality of storage cylinders and a plurality of storage cylinders, the semiconductor refrigeration part is connected into the heat preservation cylinder, and the refrigeration end of the semiconductor refrigeration part is attached to the storage cylinder and used for refrigerating insulin; the heat dissipation plate is connected into the heat preservation cylinder, and one side of the heat dissipation plate is attached to the heat dissipation end of the semiconductor refrigeration part; insulin injection pens in the storage barrels distributed in a circumferential array mode can be refrigerated at the same time, it is ensured that all the pens are in a suitable low-temperature environment, insulin is effectively stored, heat of the semiconductor refrigeration parts is conducted through the heat dissipation plate, the heat dissipation fan promotes air to flow to take away the heat, stable work of the refrigeration parts is maintained, and the continuous refrigeration capacity is ensured; the device is convenient to store, a patient can conveniently place the injection pen to be cooled, and insulin can be conveniently stored when the injection pen is daily used and carried outdoors.

A diabetes management system adapted to determine compliance of a subject in treatment according to a basal insulin regimen, the system adapted to receive regimen data, blood glucose data, and insulin injection data. If one or more insulin injections are not received in accordance with the specified regimen and thus missing, the system is adapted to calculate a predicted dose-responsive blood glucose level for each missing injection. By comparing the received blood glucose data corresponding to missing insulin injections, it may be determined whether the subject is compliant with the basal insulin regimen for a given confidence interval.

The invention provides a clamping structure and an insulin injection pen monitoring device.The clamping structure comprises an auxiliary barrel, a clamping block, a transmission gear and a power piece, the auxiliary barrel is provided with mounting channels, and the mounting channels are exposed to the two axial ends of the auxiliary barrel; the clamping block is provided with an attaching plate and a sliding point which are opposite to each other, the clamping block is inserted into the auxiliary cylinder, the attaching plate is located in the mounting channel, and the sliding point is located outside the auxiliary cylinder; the transmission gear is arranged outside the auxiliary cylinder in a sleeving mode, a sliding groove is formed in the axial end face of the transmission gear, and a sliding point of the clamping block is located in the sliding groove; the power piece is in transmission connection with the transmission gear, the power piece drives the transmission gear to rotate, the transmission gear pulls the clamping block and enables the clamping block to move in the radial direction of the auxiliary cylinder, use is convenient and fast, and meanwhile the stability of follow-up monitoring is guaranteed.

1. Name of the design product: Insulin syringe. 2. Use of the design product: For insulin injection. 3. Design key points of the design product: Lies in the shape. 4. Picture or photo that best shows the design key points: Stereogram.